Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Chamber

Immunisation Programme

Tuesday 25 March 2014 Meeting of the Parliament Debate 17 contributions · 14 speakers Watch on Scottish Parliament TV

Speakers

Showing Dr Richard Simpson only · show everyone

Dr Richard Simpson’s contributions

2 contributions
Dr Richard Simpson Lab Mid Scotland and Fife
link

Fourteen routine vaccines are given to people throughout their lives, from two months old to over 70—and the meningitis B vaccine is coming along. Despite periodic concerns about safety, immunisation, whether it is routine or additional, for travel, is one of medicine’s greatest success stories.

Recent additions, such as the shingles and rotavirus vaccines, are quickly finding their place. Rotavirus kills more than 600,000 children worldwide each year. In the UK, our wealth allows us to vaccinate more to prevent admissions than to prevent death, but in sub-Saharan Africa, rotavirus can be fatal when it is combined with bad water and poor sanitation.

All new vaccines, such as the human papillomavirus vaccine, have their critics. New vaccines should be carefully monitored as they enter the mass market.

Smallpox has been eradicated internationally. That is the effect of the first-ever vaccine, which was introduced by Jenner in 1796. Polio has been reduced to a few areas, but health workers who deliver the vaccine in north Pakistan have been murdered, through ignorance and prejudice. We should use this debate to send a message from our Parliament to support and encourage courageous health workers who risk their lives on a daily basis.

Measles cases have been reduced by 74 per cent worldwide. The global vaccine action plan, or GVAP, to which 200 countries have signed up, is a road map for extending the delivery of a basic package of vaccines.

It is estimated that 1.5 million children die each year—one every 20 seconds—from vaccine-preventable diseases. The challenge is to extend vaccines to the poorest countries. Big pharmaceutical companies are beginning to address the issue, through novel funding approaches and research into vaccines for diseases that are prevalent internationally. For example, a vaccine is in development for malaria, which is thought to cause between 1 million and 3 million deaths annually. Incidence of the disease had been reducing, and it is to be hoped that a vaccine will curb its re-emergence.

The biggest vaccine story in the United Kingdom and the western developed world at the end of the previous century and the beginning of this one was the MMR vaccine, to which the minister referred. The consequences should not be lost on politicians who supported the Wakefield fraud. It would have been bad enough if that had been the first time that a single scientist had created a storm around a vaccine, but it was not. In the 1980s, Dr Macfarlane raised concerns about the whooping cough vaccine, and the resultant drop in uptake, which was encouraged by the media, caused a re-emergence of whooping cough and young children were damaged. No proof of a problem with the pertussis vaccine was ever established and the campaign petered out.

The autism link story, which was created out of bad, unethical research, cruelly misled parents into abandoning the MMR. Opposition politicians supported the single vaccine, despite expert opinion and evidence from Japan that single vaccines were not effective. I was personally vilified in this chamber and in the press over my firm support for the triple vaccine, and some politicians berated the Labour Government for following the advice of all the royal colleges.

The result of the scandal was shown in last year’s outbreaks of measles in France and Wales. The Scottish response to the outbreak in Wales, which came on top of a significant outbreak in France and led to a call from the European Union for a significant programme of catch-up, was complacent and slow. There was no national urgency and no national campaign to update people who had missed out on the MMR vaccination. Although letters were sent to parents of children to whom the vaccine had not been administered, without a national campaign we are still at risk. There was no campaign directed at colleges and universities, where there has been an increase in the incidence of mumps as a result of the MMR scandal.

There are to be two new vaccines: the meningitis B vaccine, which is to be made available following last week’s announcement by the Joint Committee on Vaccination and Immunisation; and the HPV vaccine, in its new nine-valent form, which might be made available to boys. Patrick Harvie talked about that.

The influenza vaccine will be administered intranasally to young children. Along with the shingles and rotavirus vaccines, the influenza vaccine should be monitored to see what happens when it is put into the mass market.

Flu immunisation is very important. We made good preparation for the pandemic, and I made my own contribution to that with my report in 2001. I recommended at the time that we should stockpile Tamiflu, but I have to say to the minister that there has subsequently been much debate about how effective Tamiflu is, partly because of the failure by Roche to publish all the research timeously.

There is a big increase in the immunisation budget next year, which I assume is partly due to the new immunisations that are coming in. In reviewing the swine flu pandemic, which was fortunately not very serious, I hope that we will consider again the pandemic programme for the future and make some decisions about whether we should restock with Tamiflu.

The evidence of pressures, which we mention in our amendment, is important. It is based on the NHS Scotland staff survey, which revealed that only a third of nurses and midwives said that they could meet all the conflicting demands on their time at work and only a quarter think that there is enough staff for them to do their job properly

I have been told that midwives have refused to administer vaccines recommended for pregnant women. Such opportunistic vaccine is important, so midwives should be required to administer whooping cough vaccine in pregnancy and MMR before women leave hospital in particular. Are such practices even being monitored?

New vaccines are being introduced, with new pressures on staff. Health visitors play an important role in supporting parents—if not administering the vaccine—through an increasingly complex child vaccine programme, but the number of health visitors is determined by individual health boards. Our recent freedom of information inquiry showed that to be inadequate.

The combination of new vaccines and the demands of family-nurse partnerships and having a named person for every child means that when the Government publishes its workforce plans in June, it will have to display a degree of leadership on health visitors. Scotland has done very well with our immunisation programme.

I move amendment S4M-09446.1, to insert at end:

“; welcomes the recent additions of rotavirus and shingles vaccines and the announcement of adding meningitis B vaccine, but recognises the pressures that administering these additional vaccines and the need for the catch-up programme for the MMR vaccine place on staff”.

16:02

Dr Richard Simpson Lab Mid Scotland and Fife
link

I commend Jackson Carlaw for his speech, which identified some of the political issues in an exemplary way.

The greatest public health achievements have been the provision of clean water and sanitation and cleaner air, and the recognition—only four centuries after James VI of Scotland and I of England recognised it—of tobacco as a hazard. However, as the minister, Graeme Pearson and many others said, vaccines are one of the greatest of all the achievements, and there is no doubt that there is more to come. Jamie McGrigor was right to praise our scientists for their innovation in not only human vaccines but in veterinary science, where vaccines are also important.

Successive Governments have delivered a world-class vaccination programme and lives have been saved. We can prevent cervical cancer with the HPV vaccine rather than rely solely on cervical screening, with its shortcomings, as illustrated by Aileen McLeod. The new rotavirus vaccines, the phasing in of the intranasal influenza vaccine for children and the shingles vaccine for the over-70s will all further enhance the quality of many lives. They are worthwhile investments, as will be the meningitis B vaccine.

Patrick Harvie referred to the potential to extend the HPV vaccine to boys to achieve herd immunity. That would mirror the switch from giving the rubella vaccine only to girls—that was a difficult programme to try to eliminate rubella and prevent problems in pregnancy, as Rhoda Grant said—to having the MMR vaccine for all.

We should not forget that the international picture is different. The success in eradicating smallpox, which Jackson Carlaw referred to; the near eradication of polio; the substantial reduction in measles; the progress on addressing yellow fever; the prospect of a useful vaccine to tackle a resurgent malaria—all are welcome. As Jim Eadie said, the international programmes might be saving 2 million to 3 million lives a year.

Colin Keir was right to remind us of the deaths from Spanish flu after the first world war. Further pandemics are inevitable and we need to be prepared for them. I hope that their effect will be as soft as that of the swine flu pandemic was.

If it is validated, the new tuberculosis vaccine that is being developed in India to replace or add to the BCG will be welcome. In the meantime, we need to scrutinise our TB detection programme in at-risk groups. The rates of TB and resistant TB have risen significantly, and I am not convinced that our detection programmes are adequate.

At home, we have had the measles outbreak, although it was at nothing like the levels of the 1960s, as the minister and Nanette Milne graphically reminded us. Mumps rates have also increased because of the MMR problem, although—fortunately—not in Scotland. That suggests that the decline in uptake left by the MMR debacle has not been fully repaired.

Along with my colleague Rhoda Grant, I still have concerns that the decision not to have a national advertising campaign on MMR may yet expose some older children to all three diseases. I hope that I am wrong.

I ask for the media failures in the 1980s on pertussis and in the 1990s on MMR to be taught in college journalism courses—Joan McAlpine might be able to help us with that.

General uptake of all vaccines is good, but the degree to which uptake differs among socioeconomic groups is unclear from the routinely published data, and we should look at that as part of standard publications. Jim Eadie made a plea for us to look closely at health inequalities. The vaccines for which uptake does not meet the required percentages need to be looked at carefully to understand why that is happening, what the barriers are and whether we can improve the figures. The vaccination programme is otherwise excellent.

Like me, Graeme Pearson referred to pressures on staff, which we mention in our motion. As he said, those pressures are significant. The efforts of our staff should be applauded again—they do a fantastic job—but we need to acknowledge the pressures. I hope that midwives’ input during and post-pregnancy will be monitored, because their involvement in the vaccination programme through not only giving advice but giving vaccines merits attention.

UK’s Joint Committee on Vaccination and Immunisation may recommend more new vaccines, such as the most recent meningitis B vaccine. Joan McAlpine was right to remind us of the excellent campaign that has been run. We often rely on individuals who have suffered from our regimes’ failures to bring fully to our attention the need to undertake new measures. The recent campaign has been successful and helped the joint committee to take the step of introducing the meningitis B vaccine. Joan McAlpine also reminded us of not only the costs but the benefits from prevention in children and from reduced hospital costs and reduced time spent in hospital.

I recognise that the debate has been consensual, as it should be. We will support the Government motion and its immunisation programmes, but continue to be critical where that is appropriate.

My one concern is that we have managed to get through the whole debate without mentioning the referendum in September. The JCVI has served us well, and I wonder what our approach would be after 18 September, were we to be independent. Would we accept JCVI determinations without any Scottish representation—Scottish representatives have made a huge input—or set up our own vaccination and immunisation advisory committee, as Eire has done with its national immunisation advisory committee? What plans does the Government have in the—I hope—unlikely event of its winning that referendum?

16:50

Motions, questions and votes

Linked from this item of the Official Report

No recorded division on these motions that day: decisions taken without a vote are not in the divisions feed.

  1. Time for Reflection Time for reflection · 2
  2. Stop and Search Questions · 12
  3. Independence (Currency Union) Questions · 11
  4. Young and Novice Drivers and Graduated Driver Licensing Debate · 34
  5. Immunisation Programme Debate · 17
  6. Decision Time Decision time · 10
  7. Asda Kirkcaldy Community Life Programme Members’ business · 6
  8. Correction Procedure · 2

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.